
Francisco J. Esteva/LinkedIn
Feb 27, 2025, 11:33
Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital and a Professor of Medicine at the Zucker School of Medicine, shared an article by Kathy D. Miller, et al. on LinkedIn:
“Excited to share my latest podcast episode with Dr. Kathy Miller, where we discuss the practical implications of HER2-Low and HER2-Ultralow breast cancer.
We explore how these evolving classifications impact treatment decisions and patient care.
Listen here.
A must-listen for oncologists, surgeons, researchers, and anyone interested in the future of precision oncology!”
New Classification of HER2–Ultra-Low Breast Cancer: What Do We Need to Know?
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 23:21
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31